Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
10/2003
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2482035A1 Novel sodium channel blockers
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/28/2003US6639040 Continuous process for the production of MDI allophanates
10/28/2003CA2269897C Aminophenol derivatives and their use in cosmetics
10/23/2003WO2003087046A1 Novel aminotetraline compounds for use in mch receptor related disorders
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/22/2003EP1354871A1 Biphenyl derivatives
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/16/2003WO2003084923A1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003084922A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195202 Inhibitors of IMPDH enzyme
10/16/2003CA2481819A1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003CA2481817A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP0766674B1 New hiv protease inhibitors
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/08/2003EP0882707B1 Novel tricyclic compounds and drug compositions containing the same
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123565C Process for preparing unsymmetric phenyl substituted urea
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003CA2251003C New compounds, derivatives of n-aryl 2-hydroxyalkylamides
10/02/2003WO2003080554A2 Iodinated triglyceride analogs
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/01/2003EP1135366B1 Method of introducing melamine off-gases into a urea plant
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP0813525B1 Benzamidine derivatives their preparation and their use as anti-coagulants
10/01/2003CN1122661C Process for synthesizing unsymmetrically substituted urea herbicides
09/2003
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181442 Carbamides such as N-(3-tert-butylphenyl)-N'-(4-(3-(N-methyl-carbamoyl)phenoxy)phenyl urea, used as enzyme inhibitors and as anticarcinogenic agents
09/25/2003US20030181335 As an example, 3-(4-Cyano-3-methoxyphenyl)-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine -2,4-dione; very active herbicides and/or for the desiccation and/or defoliation of plants; better control of weeds
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/23/2003US6624280 Oligomeric and high-molecular conversion products of allophanic acid esters with nucleophilic compounds and low-molecular, oligomeric and high-molecular compounds with allophanate side and/or terminal groups, and the use thereof
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624119 3-[Benz(ox/thi)azol-7-yl]-1h-pyrimidine-2,4-diones
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/16/2003US6620961 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use
09/11/2003US20030171612 Method of preparing retroviral protease inhibitor intermediates
09/11/2003US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003CN1440964A Production process of phenyl carbamide and/or diphenyl carbamide
09/09/2003US6617413 With or without blocking, allophanate groups and free-radically polymerizable C=C double bonds in activated form by a carbonyl group attached directly or an oxygen atom in an ether function
09/09/2003US6617351 Amide, carbamate, and urea derivatives
09/09/2003US6616124 Spool valve for controlled dampers
09/09/2003CA2036770C Inhibitors of nitric oxide biosynthesis
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003US20030166961 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative
09/04/2003US20030166798 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 99